1. Home
  2. APLS vs PGNY Comparison

APLS vs PGNY Comparison

Compare APLS & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • PGNY
  • Stock Information
  • Founded
  • APLS 2009
  • PGNY 2008
  • Country
  • APLS United States
  • PGNY United States
  • Employees
  • APLS N/A
  • PGNY N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • PGNY Misc Health and Biotechnology Services
  • Sector
  • APLS Health Care
  • PGNY Health Care
  • Exchange
  • APLS Nasdaq
  • PGNY Nasdaq
  • Market Cap
  • APLS 2.2B
  • PGNY 2.0B
  • IPO Year
  • APLS 2017
  • PGNY 2019
  • Fundamental
  • Price
  • APLS $18.90
  • PGNY $23.30
  • Analyst Decision
  • APLS Buy
  • PGNY Buy
  • Analyst Count
  • APLS 19
  • PGNY 8
  • Target Price
  • APLS $37.61
  • PGNY $24.00
  • AVG Volume (30 Days)
  • APLS 2.1M
  • PGNY 1.1M
  • Earning Date
  • APLS 07-31-2025
  • PGNY 08-07-2025
  • Dividend Yield
  • APLS N/A
  • PGNY N/A
  • EPS Growth
  • APLS N/A
  • PGNY N/A
  • EPS
  • APLS N/A
  • PGNY 0.57
  • Revenue
  • APLS $775,839,000.00
  • PGNY $1,213,181,000.00
  • Revenue This Year
  • APLS $8.00
  • PGNY $7.09
  • Revenue Next Year
  • APLS $13.82
  • PGNY $11.68
  • P/E Ratio
  • APLS N/A
  • PGNY $40.95
  • Revenue Growth
  • APLS 48.04
  • PGNY 9.46
  • 52 Week Low
  • APLS $16.10
  • PGNY $13.39
  • 52 Week High
  • APLS $41.94
  • PGNY $29.65
  • Technical
  • Relative Strength Index (RSI)
  • APLS 51.99
  • PGNY 54.87
  • Support Level
  • APLS $19.16
  • PGNY $22.88
  • Resistance Level
  • APLS $20.40
  • PGNY $23.67
  • Average True Range (ATR)
  • APLS 0.93
  • PGNY 0.64
  • MACD
  • APLS -0.04
  • PGNY -0.02
  • Stochastic Oscillator
  • APLS 32.64
  • PGNY 63.29

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About PGNY Progyny Inc.

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Share on Social Networks: